[Efficacy and tolerance of the low molecular weight heparin fraction CY 216 in preventing postoperative venous thromboembolism].
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000209:etiology* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000209:etiology* / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin
Wirksamkeit und Verträglichkeit der niedermolekularen Heparinfraktion CY 216 bei der Prophylaxe postoperativer venöser thromboembolischer Prozesse.